Destriau Xavier plans to sell 40,000 ZIM ordinary shares (NYSE: ZIM)

Rhea-AI Filing Summary

Destriau Xavier filed a Form 144 reporting the proposed sale of 40,000 Ordinary shares for an aggregate amount of $1,140,004.00. The filing lists 120,465,908 shares outstanding as of 03/13/2026 as a separate context figure. The notice names the broker Oppenheimer & Co. Inc. and indicates the shares are listed on NYSE.

Insights

Securities Attorney

Form 144 notifies the market of a proposed Rule 144 resale by an affiliate.

Form 144 is a disclosure of an intended resale under Rule 144; it does not itself execute a sale. The filing shows $1,140,004.00 tied to 40,000 Ordinary shares and names Oppenheimer & Co. Inc. as broker.

Timing and completion depend on market transactions and Rule 144 conditions; subsequent Form 4/transaction reports or trade prints would show execution.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary shares	Oppenheimer & Co. Inc. 85 Broad St. New York NY 10004	45000	1224000.00	120465908	03/13/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary shares	01/24/2019	RSU	Issuer			265667	01/24/2019	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Destriau Xavier 9 ANDREI SAKHAROV STREET P.O. BOX 15067 HAIFA L3 3190500	Ordinary shares	03/11/2026	40000	1140004.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does ZIM's Form 144 filed by Destriau Xavier report?

It reports a proposed resale of 40,000 Ordinary shares for an aggregate of $1,140,004.00. The filing names Oppenheimer & Co. Inc. as broker and lists NYSE as the exchange.

Does the Form 144 confirm the shares have been sold?

No; Form 144 notifies of a proposed resale under Rule 144. It lists the planned amount and broker but does not confirm execution or settlement of the sale.

What is the significance of the 120,465,908 figure in the filing?

The filing includes 120,465,908 shares outstanding as of 03/13/2026. This is presented as a baseline context figure separate from the 40,000 shares listed for resale.

Who is the broker handling the proposed ZIM sale?

The broker named is Oppenheimer & Co. Inc. at 85 Broad St., New York, NY. The filing pairs this broker with the proposed resale of the listed shares.

Are the listed shares subject to any restrictions in this filing?

The filing identifies the shares as restricted (Rule 144 notice) and references RSU origin dates. Specific transfer restrictions or holding periods are not detailed in the excerpt.